tradingkey.logo
tradingkey.logo
Search

Denmark shares lower at close of trade; OMX Copenhagen 20 down 1.24%

Investing.comNov 7, 2024 5:00 PM
facebooktwitterlinkedin
View all comments0

Investing.com – Denmark equities were lower at the close on Thursday, as losses in the Healthcare, Real Estate and Software&Computer Services sectors propelled shares lower.

At the close in Copenhagen, the OMX Copenhagen 20 fell 1.24% to hit a new 6-month low.

The biggest gainers of the session on the OMX Copenhagen 20 were AP Moeller - Maersk A/S B (CSE:MAERSKb), which rose 5.73% or 615.00 points to trade at 11,340.00 at the close. AP Moeller - Maersk A/S A (CSE:MAERSKa) added 5.43% or 560.00 points to end at 10,870.00 and Genmab (CSE:GMAB) was up 4.33% or 66.00 points to 1,589.50 in late trade.

Biggest losers included Zealand Pharma A/S (CSE:ZELA), which lost 5.08% or 43.50 points to trade at 813.50 in late trade. NKT Holding (CSE:NKT) declined 3.38% or 21.50 points to end at 615.00 and Novo Nordisk A/S Class B (CSE:NOVOb) shed 2.60% or 19.50 points to 730.00.

Advancing stocks outnumbered falling ones by 71 to 63 and 19 ended unchanged on the Copenhagen Stock Exchange.

In commodities trading, Crude oil for December delivery was down 0.11% or 0.08 to $71.61 a barrel. Meanwhile, Brent oil for delivery in January fell 0.04% or 0.03 to hit $74.89 a barrel, while the December Gold Futures contract rose 0.96% or 25.70 to trade at $2,702.00 a troy ounce.

USD/DKK was down 0.56% to 6.91, while EUR/DKK unchanged 0.00% to 7.46.

The US Dollar Index Futures was down 0.60% at 104.35.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.